J. Hanke

发表

Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling

A. Iafrate, Xiao-Jun Ma, M. Erlander, 2007, Proceedings of the National Academy of Sciences.

Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

J. Hanke, P. Changelian, J. Gardner, 1996, The Journal of Biological Chemistry.

CTLA-4-Mediated inhibition of early events of T cell proliferation.

J. Allison, F. Chan, A. Winoto, 1999, Journal of immunology.

Protein biomarkers and drug design for cancer treatments

L. Ronco, K. Webster, J. Hanke, 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Human CD8α expression in NK cells but not cytotoxic T cells of transgenic mice

P. Kavathas, J. Mcneish, J. Hanke, 1996 .

Repetitive Alu elements form a cruciform structure that regulates the function of the human CD8 alpha T cell-specific enhancer.

P. Kavathas, J. Hanke, J. Hambor, 1995, Journal of molecular biology.

Class II positive human dermal fibroblasts restimulate cloned allospecific T cells but fail to stimulate primary allogeneic lymphoproliferation.

J. Hanke, W. Collins, M. Pollack, 1985, Human immunology.

RepetitiveAluElements form a Cruciform Structure that Regulates the Function of the Human CD8α T Cell-specific En hancer

P. Kavathas, J. Hanke, J. Hambor, 1995 .

Class II determinants recognized by TNP-specific cloned human T cell lines.

J. Hanke, M. Pollack, R. Rich, 1985, Human immunology.

Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.

J. Hanke, R. Rich, E. Mickelson, 1987, Journal of immunology.

Identification and Characterization of an Alu-Containing, T-Cell-Specific Enhancer Located in the Last Intron of the Human CD8ac Gene

P. Kavathas, J. Hanke, E. John, 2022 .

Identification of Murine Nuclear Proteins that Bind to the Octamer Control Sequence of Immunoglobulin Genes using 5’-Amino-Oligonucleotides

J. D. Capra, J. Hanke, P. Tucker, 1989 .

Molecular characterization of a subtype of DQw1 recognized by hapten-specific T cells

R. Cook, J. Hanke, R. Rich, 2004, Immunogenetics.

Identification of murine nuclear proteins that bind to the conserved octamer sequence of the immunoglobulin promoter region.

J. D. Capra, J. Hanke, P. Tucker, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Human CD8oc expression in NK cells but not cytotoxic T cells of transgenic mice

P. Kavathas, J. Mcneish, J. Hanke, 2004 .

Trinitrophenyl reactive T-cell clones in functional and molecular analysis of the HLA-D region.

R. Cook, J. Hanke, R. Rich, 1987, Advances in experimental medicine and biology.

Molecular cloning and DNA sequence analysis of the 37-kilodalton endoflagellar sheath protein gene of Treponema pallidum

J. Radolf, N. Agabian, G. Newport, 1989, Infection and immunity.

Ro/SS-A and the pathogenic significance of its antibodies.

J. D. Capra, M. Siciliano, I. Sanz, 1989, Journal of autoimmunity.

Appropriate developmental expression of human CD8 beta in transgenic mice.

P. Kavathas, J. Hanke, L. Kieffer, 1997, Journal of immunology.

The ubiquitous octamer-binding protein(s) is sufficient for transcription of immunoglobulin genes

J. D. Capra, D. Johnson, L. Carayannopoulos, 1990, Molecular and cellular biology.

Abstract 1724: Evaluation of niraparib in combination with anti-PD1/anti-PD-L1 in preclinical models

S. Ramaswamy, Yonghong Xiao, K. Sun, 2018, Immunology.

A proteomic analysis of the plasma glycoproteins of a MCF-7 mouse xenograft: a model system for the detection of tumor markers.

W. Hancock, M. Hincapie, J. Hanke, 2008, Journal of proteome research.

Role of tyrosine kinases in lymphocyte activation: Targets for drug intervention

J. Hanke, P. Changelian, B. Pollok, 1995, Inflammation Research.

Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen.

Itoh, M. Siciliano, I. Sanz, 1990, The Journal of clinical investigation.

Expression of activated CDC42 induces T cell apoptosis in thymus and peripheral lymph organs via different pathways

R. Flavell, H. Enslen, J. Hanke, 1999, Oncogene.

Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models

S. Ramaswamy, G. Mills, Yonghong Xiao, 2019, Scientific Reports.

Identification and characterization of an Alu-containing, T-cell-specific enhancer located in the last intron of the human CD8 alpha gene

P. Kavathas, J. Hanke, J. Hambor, 1993, Molecular and cellular biology.

D4-GDI, a Substrate of CPP32, Is Proteolyzed during Fas-induced Apoptosis (*)

D. Danley, G. Bokoch, J. Hanke, 1996, The Journal of Biological Chemistry.

A comparative pharmacokinetic study of PARP inhibitors demonstrates favorable properties for niraparib efficacy in preclinical tumor models

S. Ramaswamy, Gillian Smith, Zebin Wang, 2018, Oncotarget.

The src family-selective tyrosine kinase inhibitor PP1 blocks LPS and IFN-gamma-mediated TNF and iNOS production in murine macrophages.

S. L. Orlicek, J. Hanke, B. English, 1999, Shock.

NonO, a non-POU-domain-containing, octamer-binding protein, is the mammalian homolog of Drosophila nonAdiss

L. Carayannopoulos, C. Craft, J. Hanke, 1993, Molecular and cellular biology.

Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody

L. Frego, Rachel Kroe-Barrett, Sanjaya Singh, 2015, mAbs.

Targeted therapies for cancer – from tamoxifen to gefitinib (‘Iressa’)

J. Hanke, Les Hughes, 2004 .

Niraparib activates interferon signaling and potentiates anti-PD-1 antibody efficacy in tumor models

S. Ramaswamy, G. Mills, Yonghong Xiao, 2019, Scientific Reports.